Bajajfinsv FY24 Annual Earnings Summary
4 quarters covered · ₹1,10,382 Cr revenue · ₹15,595 Cr PAT · 37.0% average EBITDA margin.
Quarter-by-quarter progression
Management promises made during the year
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q2 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q2 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY24Risks flagged during the year
No price hike in motor third-party for years; frequency of accidents rising, and regulatory approval for hike is uncertain, especially in an election year.
Q1 FY24 · mediumPrivate players are aggressively bidding for crop insurance to utilize EoM allowances, potentially compressing margins for BAGIC.
Q1 FY24 · mediumHeavy rainfall in North India may lead to elevated motor and property claims, though management expects material impact to be assessed only in Q2 call.
Q1 FY24 · mediumRetail health loss ratios remain elevated due to fraud and claims inflation; management is investing in analytics but improvement may take time.
Q2 FY24 · mediumThe Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.
Q2 FY24 · mediumBAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.
Q2 FY24 · mediumAnalyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
Q2 FY24 · mediumHigher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels.
Q3 FY24 · mediumProposed IRDAI changes to surrender values could impact product profitability and persistency.
Q3 FY24 · mediumMotor insurance growth slowed to 5% due to competitive pricing and conservative underwriting stance.
Q3 FY24 · mediumBanks may prioritize deposits over third-party products, pressuring bancassurance growth.
Q4 FY24 · mediumRegulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.
What changed through the year
Q1 FY24 · BALIC to maintain NBV growth in line with past trends
Management expects absolute NBV to grow at a similar pace as historical 24% rolling 12-month growth, with margins stabilizing around 15%.
Q1 FY24 · BAGIC to sustain motor growth for 1-2 years
Expansion in distribution and geographies is expected to sustain motor growth in the medium term, though market dynamics may affect it.
Q1 FY24 · BALIC product mix to normalize from Q2
After a tactical Q1 with higher ULIP share, PAR mix is expected to revert to December 2022 levels, with corrective actions already taken in July.
Q2 FY24 · BAGIC combined ratio to be slightly above 100% for next few quarters
Due to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing.
Q2 FY24 · BALIC NBV growth expected to continue with product mix improvement
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Q2 FY24 · BFL to maintain long-term financial guidance metrics
BFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.
Q3 FY24 · Bajaj Allianz Life to maintain market-leading growth
Management expects continued strong growth in IRNB, with focus on product mix and channel diversification.
Q3 FY24 · Bajaj Allianz General to sustain above-industry growth
The company aims to grow faster than the industry in profitable segments, leveraging distribution expansion.
Q3 FY24 · Bajaj Finserv Health to scale via Vidal acquisition
The acquisition of Vidal Healthcare will accelerate Finserv Health's position in the healthcare payment spectrum.
Q3 FY24 · Bajaj Finance to resume digital card issuance soon
Deficiencies pointed out by RBI have been mostly cleared; disbursements expected to resume after regulatory approval.
Q4 FY24 · BAGIC to maintain above-market growth with balanced profitability
Management expects continued market share gains driven by distribution expansion and prudent underwriting, but no specific growth target given.
Q4 FY24 · BALIC to grow faster than industry with improving margins
Directionally, NBV margins expected to improve due to scale and cost efficiencies, though no specific numbers provided.
Q4 FY24 · Bajaj Finserv Health to integrate Vidal acquisition in Q1 FY25
Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.